-transparent.png){kind=logo}
Levels of ciprofloxacin in serum and sputum were studied for eight patients with cystic fibrosis who were infected with Pseudomonas aeruginosa. Patients were studied in a steady state on a dosage of 500 mg every 8 h. Peak levels in serum ranged from 1.27 to 5.6 mg/liter (mean, 3.16 +/- 1.27), and absorption was rapid, the time to peak concentration ranging from 0.5 to 3.0 h (mean, 1.5 +/- 0.9). The antibiotic penetrated sputum well, achieving areas under the curve of approximately 46% of those obtained in serum.
Related Publications
M J Smith, and
L O White, and
H Bowyer, and
J Willis, and
M E Hodson, and
J C Batten
January 1986,
Infection,
M J Smith, and
L O White, and
H Bowyer, and
J Willis, and
M E Hodson, and
J C Batten
January 2008,
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
M J Smith, and
L O White, and
H Bowyer, and
J Willis, and
M E Hodson, and
J C Batten
March 1982,
European journal of pediatrics,
M J Smith, and
L O White, and
H Bowyer, and
J Willis, and
M E Hodson, and
J C Batten
January 1996,
Antimicrobial agents and chemotherapy,
M J Smith, and
L O White, and
H Bowyer, and
J Willis, and
M E Hodson, and
J C Batten
August 1986,
Antimicrobial agents and chemotherapy,
M J Smith, and
L O White, and
H Bowyer, and
J Willis, and
M E Hodson, and
J C Batten
June 1987,
Antimicrobial agents and chemotherapy,
M J Smith, and
L O White, and
H Bowyer, and
J Willis, and
M E Hodson, and
J C Batten
October 1987,
The Journal of antimicrobial chemotherapy,
M J Smith, and
L O White, and
H Bowyer, and
J Willis, and
M E Hodson, and
J C Batten
March 1986,
Journal of clinical pharmacology,
M J Smith, and
L O White, and
H Bowyer, and
J Willis, and
M E Hodson, and
J C Batten
October 1985,
The American review of respiratory disease,
M J Smith, and
L O White, and
H Bowyer, and
J Willis, and
M E Hodson, and
J C Batten
January 1985,
Chemotherapy,
